affiliation not provided to SSRN
C3N5/Bi2MoO6, S-scheme heterojunction, defect engineering, Cr(VI) reduction, Antibiotic degradation
C3N5/Bi2WO6, S-scheme heterojunction, Structural defects, Antibiotic degradation, Cr(VI) reduction, Toxicity assessment